The determinants of HIV treatment costs in resource limited settings.
about
The determinants of technical efficiency of a large scale HIV prevention project: application of the DEA double bootstrap using panel data from the Indian AvahanCost drivers for voluntary medical male circumcision using primary source data from sub-Saharan Africa.Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India.Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention.The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategiesCost-Effectiveness and Quality of Care of a Comprehensive ART Program in Malawi.Annual cost of antiretroviral therapy among three service delivery models in Uganda.Costs of providing food assistance to HIV/AIDS patients in Sofala province, Mozambique: a retrospective analysis.Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India.Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at ScaleEfficiency of HIV/AIDS health centers and effect of community-based health insurance and performance-based financing on HIV/AIDS service delivery in RwandaWho pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention.The effects of decentralizing anti-retroviral services in Nigeria on costs and service utilization: two case studies.ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.PrEP Implementation Science: State-of-the-Art and Research Agenda.HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya.Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventionsInfluence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia
P2860
Q30636965-454E2C2B-5E13-4DF3-8A73-C5818D93A1BBQ30815408-AFC4CAA6-8C9E-4002-AE00-E1A36D4D73C7Q33966505-B9B363EA-F17A-4F0C-96C7-DC9CB4736797Q34002707-2F3B7E13-AE27-4A11-8AFE-606902DFFBCAQ34278022-78352053-018D-4154-929F-31D8EC55595AQ35007321-9E9AFDBB-331B-4A0E-9CF8-D0BB06672836Q35170350-50A7EF21-3339-4DAC-B54C-A3DA526BB7DAQ35561173-A4A3CB9A-F9A6-45AC-8F44-263773527338Q35850530-C6C77515-D841-4986-85E2-02B40834B5D4Q35875733-7F50193D-A0DD-4E08-9EA0-207E975D427DQ36075611-E32550EC-24A8-4477-B1F7-1276F4309466Q36289789-DD6C2EB1-8A59-4F89-8301-3D9A6F4C2CD0Q36992861-77329063-492C-4016-A4D7-6469FFB01553Q37116573-B41EFCC4-C1D7-4830-AD88-60BFC7031530Q37153151-339EBD3C-E5FA-42C7-AAB8-40A12262F553Q37244536-CD2D2745-9F8A-4AB0-8CD6-1E942A84785DQ37248645-836B023D-A35C-4BCD-885C-AA0FC34E41B7Q37343926-C4DE7901-847C-41D2-B9A6-1D128F15E0C7Q37680740-02138BCD-1020-4D76-A05F-96F47D8E61D9Q38219957-AD06A491-44C1-4A61-AE34-3803A7156446Q40923436-523C92D1-6F2C-44FF-824B-7BAFCFD78320Q43183132-FB30DD32-831E-43B7-9FDC-23E230D1C879Q43241737-4697E7C2-D33E-4403-BF5B-53E2D3696BCFQ46323776-D56DC6F3-6F9C-41EA-82D9-D5794EFABFD0Q53687071-40C8525D-7516-4AC7-9D43-A25E3D8E2B03Q58592720-BF4D8220-043E-4E41-B408-FA96652FEF68Q58592735-76713180-0A2A-4A68-A1D7-2A2033128138
P2860
The determinants of HIV treatment costs in resource limited settings.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The determinants of HIV treatment costs in resource limited settings.
@ast
The determinants of HIV treatment costs in resource limited settings.
@en
type
label
The determinants of HIV treatment costs in resource limited settings.
@ast
The determinants of HIV treatment costs in resource limited settings.
@en
prefLabel
The determinants of HIV treatment costs in resource limited settings.
@ast
The determinants of HIV treatment costs in resource limited settings.
@en
P2093
P2860
P1433
P1476
The determinants of HIV treatment costs in resource limited settings.
@en
P2093
Andres A Berruti
John M Blandford
Nicolas A Menzies
P2860
P304
P356
10.1371/JOURNAL.PONE.0048726
P407
P577
2012-11-07T00:00:00Z